Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-10

FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' original abbreviated new drug application for fluoxetine hydrochloride (generic fluoxetine), authorizing a generic formula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

ORIG AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)